✦ LIBER ✦

Model for end-stage liver disease (MELD) exception for bacterial cholangitis

✍ Scribed by Gregory J. Gores; Robert G. Gish; Roshan Shrestha; Russell H. Wiesner

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 60 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20966

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception guidelines

✍ Russell Wiesner; John R. Lake; Richard B. Freeman; Robert G. Gish 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for ascites

✍ Scott W. Biggins; Steven Colquhoun; Robert G. Gish; Bruce A. Runyon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for polycystic liver disease

✍ Luis Arrazola; Dilip Moonka; Robert G. Gish; Gregory T. Everson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for cystic fibrosis

✍ Simon Horslen; Stuart Sweet; Robert G. Gish; Ross Shepherd 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Cystic fibrosis (CF) is a multisystem disease caused by mutations in a single gene (cystic fibrosis transmembrane conductance regulator) and is the most frequent potentially fatal inherited condition in whites, occurring in 1 in 2,000 births. Progressive pulmonary disease is the major contributor to

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for hepatic encephalopathy

✍ John Ham; Robert G. Gish; Kevin Mullen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome

✍ Michael B. Fallon; David C. Mulligan; Robert G. Gish; Michael J. Krowka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Hepatopulmonary syndrome (HPS) occurs when intrapulmonary vascular dilatation leads to abnormal arterial gas exchange in the setting of liver disease and/or portal hypertension. 1 Over the past 15 years, HPS has emerged as a relatively common complication of cirrhosis, occurring in 15 to 20% of case